Often, therapeutic development has focused on tiny agents, but amino acid partners are progressively gaining momentum. This innovative methodology involves combining peptides with alternative therapeutic modalities to address challenging illness mechanisms. By leveraging the specific properties of amino acid sequences – check here such as signifi